Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.
Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 11,732 | $809,525 | 0 | $0 |
2024 | 0 | $0 | 255,921 | $21,765,611 | 199,347 | $12,744,795 |
2023 | 0 | $0 | 291,124 | $29,165,285 | 298,974 | $20,261,651 |
2022 | 3,625 | $314,468 | 311,275 | $27,255,098 | 253,242 | $11,640,873 |
2021 | 0 | $0 | 191,799 | $15,370,940 | 178,931 | $4,916,104 |
2020 | 12,800 | $1,005,145 | 360,561 | $39,226,570 | 301,650 | $13,887,132 |
2019 | 0 | $0 | 186,014 | $16,384,008 | 131,953 | $2,232,548 |
2018 | 0 | $0 | 443,177 | $39,824,783 | 396,390 | $13,170,758 |
2017 | 0 | $0 | 308,037 | $28,193,855 | 265,930 | $7,893,265 |
2016 | 0 | $0 | 1,279,525 | $111,508,495 | 1,208,448 | $28,339,513 |
2015 | 0 | $0 | 411,289 | $48,410,265 | 295,446 | $6,663,831 |
2014 | 0 | $0 | 340,526 | $26,836,672 | 306,781 | $7,721,726 |
2013 | 0 | $0 | 742,342 | $47,391,614 | 730,412 | $15,099,577 |
2012 | 0 | $0 | 1,247,954 | $51,415,184 | 1,198,637 | $17,833,395 |
2011 | 0 | $0 | 332,106 | $9,638,946 | 335,054 | $4,369,131 |
2010 | 800 | $16,062 | 564,962 | $13,310,700 | 545,102 | $7,510,310 |
2009 | 26,500 | $306,434 | 74,572 | $1,277,220 | 83,753 | $455,350 |
2008 | 16,752 | $218,171 | 1,172,420 | $39,560,526 | 973,113 | $8,505,589 |
2007 | 17,587 | $107,335 | 576,356 | $12,583,816 | 477,563 | $3,277,058 |
2006 | 35,493 | $362,571 | 184,500 | $2,780,052 | 284,500 | $1,766,260 |
2005 | 12,000 | $103,551 | 81,142 | $826,127 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-12-04 | Davis George Eric (VP, General Counsel) | Sale | 7,000 | 16.30 | 114,079 |
2008-12-03 | Lapalme Pierre (Director) | Buy | 2,400 | 15.29 | 36,703 |
2008-12-01 | Kakkis Emil D (CHIEF MEDICAL OFFICER) | Sale | 17,000 | 15.87 | 269,790 |
2008-12-01 | Kakkis Emil D (CHIEF MEDICAL OFFICER) | Option Ex | 17,000 | 6.13 | 104,210 |
2008-11-28 | Wood Mark (VP, Human Resources) | Sale | 177 | 16.50 | 2,920 |
2008-11-28 | Wood Mark (VP, Human Resources) | Option Ex | 177 | 6.13 | 1,085 |
2008-11-25 | Kakkis Emil D (Chief Medical Officer) | Sale | 75,000 | 15.98 | 1,198,725 |
2008-11-03 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 33,000 | 12.12 | 400,026 |
2008-10-31 | Davis George Eric (VP, General Counsel) | Buy | 186 | 13.35 | 2,483 |
2008-10-31 | Kakkis Emil D (Chief Medical Officer) | Buy | 317 | 13.35 | 4,233 |
2008-10-21 | Wood Mark (VP, Human Resources) | Sale | 177 | 20.22 | 3,578 |
2008-10-21 | Wood Mark (VP, Human Resources) | Option Ex | 177 | 6.13 | 1,085 |
2008-10-01 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 26.27 | 472,878 |
2008-10-01 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 18,000 | 6.13 | 110,340 |
2008-09-22 | Wood Mark (VP, Human Resources) | Sale | 2,468 | 28.33 | 69,915 |
2008-09-22 | Wood Mark (VP, Human Resources) | Option Ex | 2,468 | 13.35 | 32,942 |
2008-09-02 | Baffi Robert (SVP, Technical Operations) | Sale | 11,528 | 31.31 | 360,964 |
2008-09-02 | Baffi Robert (SVP, Technical Operations) | Option Ex | 11,528 | 22.00 | 253,616 |
2008-09-02 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 30.19 | 543,384 |
2008-09-02 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 6,000 | 6.13 | 36,780 |
2008-08-21 | Wood Mark (VP, Human Resources) | Sale | 2,469 | 26.10 | 64,435 |
2008-08-21 | Wood Mark (VP, Human Resources) | Option Ex | 2,469 | 13.35 | 32,956 |
2008-08-11 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 600 | 6.46 | 3,876 |
2008-08-08 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 650 | 6.46 | 4,199 |
2008-08-07 | Bienaime Jean Jacques (Chief Executive Office) | Option Ex | 1,000 | 6.46 | 6,460 |
2008-08-06 | Bienaime Jean Jacques (Chief Executive Office) | Option Ex | 1,200 | 6.46 | 7,752 |
2008-08-01 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 32.46 | 584,352 |
2008-07-30 | Baffi Robert (SVP, Technical Operations) | Sale | 19,528 | 31.75 | 620,160 |
2008-07-30 | Baffi Robert (SVP, Technical Operations) | Option Ex | 19,528 | 22.00 | 429,616 |
2008-07-21 | Wood Mark (VP, Human Resources) | Sale | 2,468 | 30.25 | 74,657 |
2008-07-21 | Wood Mark (VP, Human Resources) | Option Ex | 2,468 | 13.35 | 32,942 |
2008-07-15 | Davis George Eric (VP, General Counsel) | Sale | 5,000 | 28.00 | 140,000 |
2008-07-15 | Davis George Eric (VP, General Counsel) | Option Ex | 5,000 | 6.13 | 30,650 |
2008-07-08 | Wood Mark (VP, Human Resources) | Sale | 350 | 28.20 | 9,868 |
2008-07-07 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 28.04 | 504,792 |
2008-07-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 15,000 | 28.34 | 425,175 |
2008-07-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 15,000 | 6.13 | 91,950 |
2008-06-30 | Baffi Robert (SVP, Technical Operations) | Sale | 3,528 | 30.02 | 105,924 |
2008-06-30 | Baffi Robert (SVP, Technical Operations) | Option Ex | 3,528 | 22.00 | 77,616 |
2008-06-23 | Wood Mark (VP, Human Resources) | Sale | 2,292 | 32.61 | 74,735 |
2008-06-23 | Wood Mark (VP, Human Resources) | Option Ex | 2,292 | 15.15 | 34,728 |
2008-06-16 | Davis George Eric (VP, General Counsel) | Option Ex | 10,000 | 7.84 | 78,400 |
2008-06-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 3,000 | 39.00 | 117,000 |
2008-06-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 6.46 | 19,380 |
2008-06-04 | Wood Mark (VP, Human Resources) | Sale | 1,323 | 37.66 | 49,825 |
2008-06-04 | Wood Mark (VP, Human Resources) | Option Ex | 1,323 | 12.56 | 16,611 |
2008-06-02 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 37.63 | 677,286 |
2008-06-02 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 16,000 | 4.00 | 64,000 |
2008-05-30 | Baffi Robert (SVP, Technical Operatons) | Sale | 11,528 | 38.57 | 443,395 |
2008-05-30 | Baffi Robert (SVP, Technical Operations) | Option Ex | 11,528 | 22.00 | 253,616 |
2008-05-21 | Wood Mark (VP, Human Resources) | Sale | 1,667 | 39.17 | 65,298 |
2008-05-21 | Wood Mark (VP, Human Resources) | Option Ex | 1,667 | 11.81 | 19,692 |
2008-05-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 39.10 | 195,524 |
2008-05-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 6.46 | 32,300 |
2008-05-13 | Davis George Eric (VP, General Counsel) | Sale | 10,000 | 39.15 | 391,520 |
2008-05-13 | Davis George Eric (VP, General Counsel) | Option Ex | 10,000 | 11.74 | 117,400 |
2008-05-12 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 39.18 | 195,890 |
2008-05-12 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 6.46 | 32,300 |
2008-05-09 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 8,000 | 39.04 | 312,320 |
2008-05-09 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 8,000 | 6.46 | 51,680 |
2008-05-06 | Aselage Steve (SVP, Global Commercial Dev.) | Sale | 16,200 | 37.75 | 611,550 |
2008-05-06 | Aselage Steve (SVP, Global Commercial Dev.) | Option Ex | 12,205 | 9.45 | 115,337 |
2008-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 36.55 | 182,775 |
2008-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 6.46 | 32,300 |
2008-05-02 | Aselage Steve (SVP, Global Commercial Dev.) | Sale | 3,800 | 37.75 | 143,450 |
2008-05-02 | Aselage Steve (SVP, Global Commercial Dev.) | Option Ex | 2,900 | 7.16 | 20,764 |
2008-05-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,100 | 36.87 | 372,387 |
2008-05-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 10,000 | 6.46 | 64,600 |
2008-05-01 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 37.46 | 674,262 |
2008-05-01 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 18,000 | 4.00 | 72,000 |
2008-05-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 7,453 | 37.21 | 277,341 |
2008-05-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 6.46 | 32,300 |
2008-04-30 | Davis George Eric (VP, General Counsel) | Buy | 1,810 | 10.37 | 18,769 |
2008-04-30 | Davis George Eric (VP, General Counsel) | Sale | 5,000 | 36.51 | 181,626 |
2008-04-30 | Davis George Eric (VP, General Counsel) | Option Ex | 5,000 | 7.84 | 39,200 |
2008-04-30 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Buy | 1,070 | 13.95 | 14,925 |
2008-04-30 | Baffi Robert (SVP, Technical Operations) | Buy | 1,754 | 10.37 | 18,188 |
2008-04-30 | Kakkis Emil D (Chief Medical Officer) | Buy | 1,640 | 10.37 | 17,006 |
2008-04-30 | Aselage Steve (SVP, Global Commercial Dev.) | Buy | 1,526 | 10.37 | 15,824 |
2008-04-30 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 2,049 | 10.37 | 21,248 |
2008-04-29 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 75,000 | 4.00 | 300,000 |
2008-04-21 | Wood Mark (VP, Human Resources) | Sale | 2,990 | 33.99 | 101,618 |
2008-04-21 | Wood Mark (VP, Human Resources) | Option Ex | 2,990 | 12.19 | 36,433 |
2008-04-02 | Baffi Robert (SVP, Technical Operations) | Sale | 38,762 | 36.99 | 1,432,894 |
2008-04-02 | Baffi Robert (SVP, Technical Operations) | Option Ex | 38,762 | 6.95 | 269,202 |
2008-04-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 35.95 | 449,400 |
2008-04-01 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 6.13 | 76,625 |
2008-04-01 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 35.84 | 645,189 |
2008-04-01 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 18,000 | 4.00 | 72,000 |
2008-04-01 | Aselage Steve (SVP, Global Commercial Dev) | Sale | 805 | 35.98 | 28,963 |
2008-04-01 | Aselage Steve (SVP, Global Commercial Dev) | Option Ex | 805 | 7.16 | 5,763 |
2008-03-25 | Baffi Robert (SVP, Technical Operations) | Sale | 34,998 | 35.87 | 1,256,096 |
2008-03-25 | Baffi Robert (SVP, Technical Operations) | Option Ex | 34,998 | 9.93 | 347,530 |
2008-03-24 | Wood Mark (VP, Human Resources) | Sale | 2,989 | 35.05 | 104,758 |
2008-03-24 | Wood Mark (VP, Human Resources) | Option Ex | 2,989 | 12.19 | 36,420 |
2008-03-18 | Baffi Robert (SVP, Technical Operations) | Sale | 46,240 | 32.44 | 1,498,432 |
2008-03-18 | Baffi Robert (SVP, Technical Operations) | Option Ex | 46,240 | 12.10 | 559,504 |
2008-03-14 | Baffi Robert (SVP, Technical Operations) | Sale | 76,486 | 33.11 | 2,556,386 |
2008-03-14 | Baffi Robert (SVP, Technical Operations) | Option Ex | 76,486 | 9.50 | 726,616 |
2008-03-06 | Kakkis Emil D (Chief Medical Officer) | Sale | 18,000 | 38.15 | 686,610 |
2008-03-06 | Kakkis Emil D (Chief Medical Officer) | Option Ex | 18,000 | 4.00 | 72,000 |
2008-03-06 | Heron Elaine J (Director) | Sale | 30,000 | 37.95 | 1,139,683 |
2008-03-06 | Heron Elaine J (Director) | Option Ex | 60,000 | 7.75 | 465,000 |
2008-03-05 | Grey Michael G (Director) | Sale | 25,000 | 38.30 | 955,555 |
2008-03-05 | Grey Michael G (Director) | Option Ex | 30,000 | 10.33 | 309,900 |
2008-03-04 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 38.00 | 152,000 |
2008-03-04 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 6.46 | 25,840 |
2008-03-03 | Davis George Eric (VP, General Counsel) | Sale | 20,000 | 38.00 | 760,000 |
2008-03-03 | Davis George Eric (VP, General Counsel) | Option Ex | 20,000 | 6.99 | 139,700 |
2008-03-03 | Heron Elaine J (Director) | Sale | 20,000 | 38.47 | 769,400 |
2008-03-03 | Aselage Steve (SVP, Global Commercial Dev) | Sale | 40,000 | 38.00 | 1,520,000 |
2008-03-03 | Aselage Steve (SVP, Global Commercial Dev) | Option Ex | 65,000 | 9.45 | 614,250 |
2008-03-03 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 2,000 | 38.13 | 76,262 |
2008-03-03 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 2,000 | 6.46 | 12,920 |
2008-03-03 | Klein Joseph Iii (Director) | Sale | 10,000 | 38.05 | 380,550 |
2008-02-29 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 55,625 | 37.80 | 2,096,636 |
2008-02-29 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 55,625 | 7.78 | 432,540 |
2008-02-29 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 21,142 | 38.11 | 805,700 |
2008-02-29 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 18,000 | 6.46 | 116,280 |
2008-02-29 | Klein Joseph Iii (Director) | Option Ex | 30,000 | 14.21 | 426,300 |
2008-02-29 | Lapalme Pierre (Director) | Sale | 15,000 | 38.02 | 569,531 |
2008-02-29 | Lapalme Pierre (Director) | Option Ex | 15,000 | 5.92 | 88,800 |
2008-01-22 | Wood Mark (VP, Human Resources) | Sale | 2,990 | 36.31 | 108,572 |
2008-01-22 | Wood Mark (VP, Human Resources) | Option Ex | 2,990 | 12.19 | 36,433 |
2008-01-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Sale | 12,500 | 36.16 | 452,037 |
2008-01-02 | Swiedler Stuart J (SVP, Clinical Affairs) | Option Ex | 12,500 | 6.13 | 76,625 |
2008-01-02 | Aselage Steve (SVP, Global Commercial Dev) | Sale | 5,000 | 36.09 | 180,475 |
2008-01-02 | Aselage Steve (SVP, Global Commercial Dev) | Option Ex | 5,000 | 7.16 | 35,800 |
2008-01-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 15,000 | 36.09 | 541,410 |
2008-01-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 6.46 | 96,900 |
2007-12-21 | Wood Mark (VP, Human Resources) | Sale | 6,114 | 36.08 | 220,562 |
2007-12-21 | Wood Mark (VP, Human Resources) | Option Ex | 6,114 | 12.19 | 74,499 |
2007-12-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 15,000 | 35.53 | 532,980 |
2007-12-17 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 15,000 | 6.46 | 96,900 |
2007-11-21 | Wood Mark (VP, Human Resources) | Sale | 2,365 | 25.82 | 61,052 |
2007-11-21 | Wood Mark (VP, Human Resources) | Option Ex | 2,365 | 11.16 | 26,383 |
2007-10-31 | Kakkis Emil D (Chief Medical Officer) | Buy | 2,038 | 6.92 | 14,100 |
2007-10-31 | Aselage Steve (SVP, Global Commercial Dev) | Buy | 2,139 | 6.92 | 14,799 |
2007-10-31 | Bienaime Jean Jacques (Chief Executive Officer) | Buy | 518 | 6.92 | 3,584 |
2007-10-24 | Wood Mark (VP, Human Resources) | Sale | 833 | 26.00 | 21,658 |
2007-10-24 | Wood Mark (VP, Human Resources) | Option Ex | 833 | 17.54 | 14,610 |
2007-10-22 | Wood Mark (VP, Human Resources) | Sale | 1,532 | 25.30 | 38,761 |
2007-10-22 | Wood Mark (VP, Human Resources) | Option Ex | 1,532 | 9.56 | 14,645 |
2007-10-11 | Davis George Eric (VP, General Counsel) | Sale | 5,000 | 27.34 | 136,700 |
2007-10-11 | Davis George Eric (VP, General Counsel) | Option Ex | 5,000 | 8.05 | 40,250 |
2007-10-08 | Wood Mark (VP, Human Resources) | Sale | 8,333 | 26.00 | 216,658 |
2007-10-08 | Wood Mark (VP, Human Resources) | Option Ex | 8,333 | 17.54 | 146,160 |
2007-10-08 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Sale | 12,380 | 26.00 | 321,880 |
2007-10-08 | Cooper Jeffrey H (SVP, Chief Financial Officer) | Option Ex | 12,380 | 8.10 | 100,278 |
2007-10-01 | Davis George Eric (VP, General Counsel) | Sale | 5,000 | 25.10 | 125,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.